Sean A Fletcher
Overview
Explore the profile of Sean A Fletcher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pallauf M, Rezaee M, Elias R, Wlajnitz T, Fletcher S, Cheaib J, et al.
BJU Int
. 2025 Jan;
PMID: 39873312
Objective: To evaluate the association between tumour size and the growth rate (GR) of small renal masses (SRMs) in patients managed by active surveillance (AS). Materials And Methods: We queried...
2.
Pallauf M, Bronimann S, Rezaee M, Kohn T, Fletcher S, McNamara M, et al.
Urol Oncol
. 2025 Jan;
PMID: 39848843
Purpose: To investigate the association of diabetes mellitus and metformin use with metabolic acidosis risk after radical cystectomy (RC) and urinary diversion for bladder cancer. Materials And Methods: This retrospective...
3.
Fletcher S, Schendzielos R, Rezaee M, Lum Y, Singla N
Kidney Cancer J
. 2024 Oct;
22(2):46-52.
PMID: 39435380
Introduction: Performing surgery for renal cell carcinoma (RCC) in patients with horseshoe kidneys presents unique anatomic challenges. The complexities of clinical decision-making and technical challenges are further compounded by the...
4.
Bhanji Y, Mamawala M, Fletcher S, Landis P, Patel H, Macura K, et al.
J Urol
. 2024 Oct;
213(1):20-26.
PMID: 39357025
Purpose: Men diagnosed with prostate cancer (PCa) considering active surveillance (AS) are recommended confirmatory biopsy (CBx). Whether this is necessary in the era of MRI-informed biopsies is questionable. Materials And...
5.
6.
Rezaee M, Pallauf M, Fletcher S, Han M, Pavlovich C, Ding C, et al.
AUA News
. 2024 Aug;
2024(Extra).
PMID: 39156183
No abstract available.
7.
Hyndman M, Paproski R, Kinnaird A, Fairey A, Marks L, Pavlovich C, et al.
NPJ Digit Med
. 2024 Jun;
7(1):163.
PMID: 38902526
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment...
8.
Fletcher S, Mamawala M, Holler A, Bhanji Y, Macura K, de la Calle C, et al.
Prostate
. 2024 Mar;
84(8):723-730.
PMID: 38476030
Background: To validate the use of a cumulative cancer locations (CCLO) score, a measurement of tumor volume on biopsy, and to develop a novel magnetic resonance imaging (MRI)-informed CCLO (mCCLO)...
9.
Hung M, Ross A, Li E, Pavlovich C, Fletcher S, Gereta S, et al.
Urology
. 2024 Feb;
186:91-97.
PMID: 38387509
Objective: To compare clinically significant prostate cancer detection with TP-TBx utilizing software vs cognitive fusion. It is established that MRI prior to prostate biopsy improves detection of clinically significant cancer...
10.
Rezaee M, Pallauf M, Fletcher S, Pavlovich C, Baraban E, Ged Y, et al.
Urol Oncol
. 2024 Feb;
42(4):119.e23-119.e29.
PMID: 38355353
Objective: To examine the prognostic significance of perinephric fat, renal sinus fat, and renal vein invasion in patients with pT3a renal cell carcinoma (RCC) by histologic type. Methods: A population-based...